Movatterモバイル変換

[0]ホーム
URL:

IN2012DN00791A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00791A
IN2012DN00791AIN791DEN2012AIN2012DN00791AIN 2012DN00791 AIN2012DN00791 AIN 2012DN00791AIN 791DEN2012 AIN791DEN2012 AIN 791DEN2012AIN 2012DN00791 AIN2012DN00791 AIN 2012DN00791A
Authority
IN
India
Prior art keywords
streptococcus pneumoniae
prophylactically
elderly
antigens
young
Prior art date
Application number
Inventor
Todd Gierahn
Richard Malley
Original Assignee
Genocea Biosciences Inc
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genocea Biosciences Inc, Childrens Medical CenterfiledCriticalGenocea Biosciences Inc
Publication of IN2012DN00791ApublicationCriticalpatent/IN2012DN00791A/en

Links

Classifications

Landscapes

Abstract

Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in Streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
IN791DEN20122009-06-292010-06-29IN2012DN00791A (en)

Applications Claiming Priority (5)

Application NumberPriority DateFiling DateTitle
US22154109P2009-06-292009-06-29
US24059809P2009-09-082009-09-08
US24061609P2009-09-082009-09-08
US31626710P2010-03-222010-03-22
PCT/US2010/040406WO2011008548A1 (en)2009-06-292010-06-29Vaccines and compositions against streptococcus pneumoniae

Publications (1)

Publication NumberPublication Date
IN2012DN00791Atrue IN2012DN00791A (en)2015-06-26

Family

ID=43449681

Family Applications (1)

Application NumberTitlePriority DateFiling Date
IN791DEN2012IN2012DN00791A (en)2009-06-292010-06-29

Country Status (15)

CountryLink
US (2)US10105412B2 (en)
EP (1)EP2448592B1 (en)
JP (1)JP5931724B2 (en)
KR (1)KR101748453B1 (en)
CN (2)CN102548572A (en)
AU (1)AU2010273708B2 (en)
BR (1)BRPI1011919A2 (en)
CA (1)CA2803061A1 (en)
IL (1)IL217166A0 (en)
IN (1)IN2012DN00791A (en)
MX (1)MX2012000158A (en)
NZ (1)NZ597858A (en)
RU (1)RU2580299C2 (en)
SG (2)SG10201403702SA (en)
WO (1)WO2011008548A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
BRPI1011919A2 (en)2009-06-292017-09-26Childrens Medical Center Streptococcus pneumoniae vaccines and compositions
WO2011112906A2 (en)2010-03-122011-09-15Children's Medical Center CorporationNovel immunogens and methods for discovery and screening thereof
WO2012085099A1 (en)*2010-12-212012-06-28MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.Determination of the efficacy of an anti-mycobacterial vaccination
WO2012100233A1 (en)*2011-01-202012-07-26Genocea Biosciences, Inc.Vaccines and compositions against streptococcus pneumoniae
TW201249824A (en)*2011-03-092012-12-16Glaxosmithkline LlcPeptide deformylase inhibitors
CN108840912B (en)*2011-05-112023-07-04儿童医疗中心有限公司 Modified biotin-binding protein and its fusion protein and application
JP6379041B2 (en)*2012-01-202018-08-22ジェノセア バイオサイエンシーズ， インコーポレイテッド Fusion antigen vaccines and compositions for Streptococcus pneumoniae
WO2014018904A1 (en)*2012-07-262014-01-30Genocea Biosciences, Inc.Fused antigen vaccines and compositions against streptococcus pneumoniae
ES2959258T3 (en)2013-02-072024-02-22Childrens Medical Center Protein antigens that provide protection against pneumococcal colonization and/or disease
US20150079132A1 (en)*2013-09-172015-03-19PathEvoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantly
WO2015161218A1 (en)*2014-04-182015-10-22Children's Medical Center CorporationVaccine adjuvant compositions
US9107906B1 (en)2014-10-282015-08-18Adma Biologics, Inc.Compositions and methods for the treatment of immunodeficiency
US11413344B2 (en)2017-01-202022-08-16Pfizer Inc.Immunogenic compositions for use in pneumococcal vaccines
US10259865B2 (en)2017-03-152019-04-16Adma Biologics, Inc.Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
AU2018243910B2 (en)2017-03-282025-04-10The Children's Medical Center CorporationA multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
SG11201912601RA (en)2017-06-232020-01-30Nosocomial Vaccine CorpImmunogenic compositions
US12239702B2 (en)2017-12-042025-03-04Intervet Inc.Vaccination with replicon particles and oil adjuvant
SG11202102007UA (en)2018-09-122021-03-30Affinivax IncMultivalent pneumococcal vaccines
EP3849599A4 (en)2018-09-122022-06-29The Children's Medical Center CorporationPneumococcal fusion protein vaccines
RU2728938C1 (en)*2020-05-062020-08-03Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России)Use of dalargin for production of drug preparations for preventing pneumonia
WO2022013160A1 (en)2020-07-162022-01-20Henriques Normark BirgittaStreptococcal vaccines
EP4398933A1 (en)2021-09-092024-07-17Affinivax, Inc.Multivalent pneumococcal vaccines

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CA2059692C (en)*1991-01-282004-11-16Peter J. KniskernPneumoccoccal polysaccharide conjugate vaccine
US5371197A (en)*1991-09-241994-12-06Merck & Co., Inc.Protein-dimeric polysaccharide conjugate vaccine
US5505947A (en)*1994-05-271996-04-09The University Of North Carolina At Chapel HillAttenuating mutations in Venezuelan Equine Encephalitis virus
JP2000511769A (en)1996-04-022000-09-12スミスクライン・ビーチャム・コーポレイション New compound
PT942983E (en)1996-10-312007-02-28Human Genome Sciences IncStreptococcus pneumoniae antigens and vaccines
EP1002090A2 (en)1997-05-062000-05-24Human Genome Sciences, Inc.$i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
AU8151898A (en)1997-06-201999-01-04Human Genome Sciences, Inc.Lyme disease vaccines
US6800744B1 (en)*1997-07-022004-10-05Genome Therapeutics CorporationNucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US5882885A (en)*1997-07-171999-03-16Smithkline Beecham CorporationGlycogen phosphorylase
US5994101A (en)*1997-07-181999-11-30Smithkline Beecham CorporationDNA encoding gidA1 polypeptides
US6617156B1 (en)*1997-08-152003-09-09Lynn A. Doucette-StammNucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US6248558B1 (en)1998-03-312001-06-19Vanderbilt UniversitySequence and method for genetic engineering of proteins with cell membrane translocating activity
WO2000006738A2 (en)1998-07-272000-02-10Microbial Technics LimitedNUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
US6887480B1 (en)*1999-06-102005-05-03Medimmune, Inc.Streptococcus pneumoniae proteins and vaccines
JP2003501110A (en)1999-06-102003-01-14メディミューン，インコーポレーテッド S. pneumoniae proteins and vaccines
EP1240332B1 (en)*1999-12-232008-01-23Vmax LimitedStreptococcus pyogenes virulence genes and proteins and their use
US6783939B2 (en)*2000-07-072004-08-31Alphavax, Inc.Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
EP2284182A1 (en)*2000-10-272011-02-16Novartis Vaccines and Diagnostics S.r.l.Nucleic acids and proteins from streptococcus groups A and B
GB0107658D0 (en)*2001-03-272001-05-16Chiron SpaStreptococcus pneumoniae
JP2005501518A (en)2001-04-162005-01-20ワイス・ホールディングズ・コーポレイション Novel Streptococcus pneumoniae open reading frame encoding polypeptide antigen and use thereof
US20040029129A1 (en)*2001-10-252004-02-12Liangsu WangIdentification of essential genes in microorganisms
US7314974B2 (en)*2002-02-212008-01-01Monsanto Technology, LlcExpression of microbial proteins in plants for production of plants with improved properties
CA2481107A1 (en)2002-04-022003-10-09Yaffa Mizrachi NebenzahlProtein-based streptococcus pneumoniae vaccines
US20090252756A1 (en)*2002-04-022009-10-08Yaffa Mizrachi-NebenzahlProtein-based streptococcus pneumoniae vaccines
WO2004018646A2 (en)2002-08-262004-03-04Chiron CorporationConserved and specific streptococcal genomes
WO2004020609A2 (en)2002-08-302004-03-11Tufts UniversityStreptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
EP2311991A1 (en)*2003-04-152011-04-20Intercell AGS. pneumoniae antigens
GB0318688D0 (en)*2003-08-082003-09-10Chiron SrlStreptococcus pneumoniae knockout mutants
US20090104218A1 (en)2004-12-222009-04-23J. Craig Venter InstituteGroup B Streptococcus
EP1855717A4 (en)2005-02-112009-12-23Ace Biosciences AsSurface-located streptococcus pneumoniae polypeptides
US20110177960A1 (en)*2006-03-102011-07-21Ellen MurphyMicroarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae
US20100015168A1 (en)*2006-06-092010-01-21Novartis AgImmunogenic compositions for streptococcus agalactiae
GB0700136D0 (en)*2007-01-042007-02-14Glaxosmithkline Biolog SaProcess for manufacturing vaccines
WO2008119358A2 (en)2007-03-302008-10-09Ace Biosciences A/SSurface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
CN101855362A (en)2007-05-182010-10-06美国政府健康及人类服务部，疾病控制和预防中心 Primers and probes for the detection of Streptococcus pneumoniae
CN101848929A (en)2007-05-252010-09-29诺华有限公司Streptococcus pneumoniae pilus antigens
WO2008150885A1 (en)*2007-05-292008-12-11Board Of Regents, The University Of Texas SystemModulation of the th-17 cell mediated immune responses
GB0714963D0 (en)*2007-08-012007-09-12Novartis AgCompositions comprising antigens
EP2225265A2 (en)*2007-09-142010-09-08Katholieke Universiteit LeuvenStreptococcus pneumoniae vaccines
US8466259B2 (en)*2007-12-072013-06-18National Health Research InstitutesAdjuvants
US7833776B2 (en)*2007-12-122010-11-16National Health Research InstitutesLipidating sequences and use thereof for producing lipidated proteins in E. coli
WO2009114207A2 (en)*2008-03-142009-09-17Sanofi Pasteur Biologics Co.Replication-defective flavivirus vaccines and vaccine vectors
EP3839512A1 (en)2008-07-012021-06-23Genocea Biosciences, Inc.Methods of identifying infections and related conditions
US20110236470A1 (en)2008-12-032011-09-29Yaffa Mizrachi NebenzahlGLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
US8287880B2 (en)*2009-06-022012-10-16National Health Research InstitutesLipidated vaccine against dengue virus infection
TWI409275B (en)*2009-06-222013-09-21Nat Health Research InstitutesLipidated tumor-associated antigens and immunotherapeutic compositions
US20120100172A1 (en)*2009-06-252012-04-26Michael TalImmunogenic streptococcus pneumoniae peptides and peptide-multimers
BRPI1011919A2 (en)2009-06-292017-09-26Childrens Medical Center Streptococcus pneumoniae vaccines and compositions
WO2011064781A1 (en)2009-11-302011-06-03Ben-Gurion University Of The Negev Research And Development AuthorityS. pneumoniae adhesins
WO2011067758A2 (en)2009-12-022011-06-09Protea Vaccine Technologies Ltd.Immunogenic fragments and multimers from streptococcus pneumoniae proteins
JP5065434B2 (en)*2010-04-062012-10-31株式会社日立製作所 Management method and management apparatus
WO2011128892A2 (en)2010-04-122011-10-20Protea Vaccine Technologies Ltd.Modified forms of pneumococcal surface immunogenic protein b (psipb)
US20110283062A1 (en)*2010-05-142011-11-17Hitachi, Ltd.Storage apparatus and data retaining method for storage apparatus
WO2012100233A1 (en)*2011-01-202012-07-26Genocea Biosciences, Inc.Vaccines and compositions against streptococcus pneumoniae

Also Published As

Publication numberPublication date
BRPI1011919A2 (en)2017-09-26
AU2010273708A1 (en)2012-02-23
KR101748453B1 (en)2017-06-16
US20190298795A1 (en)2019-10-03
CA2803061A1 (en)2011-01-20
KR20120093141A (en)2012-08-22
JP2012532134A (en)2012-12-13
IL217166A0 (en)2012-02-29
US20110020386A1 (en)2011-01-27
AU2010273708B2 (en)2015-10-01
SG177402A1 (en)2012-02-28
WO2011008548A1 (en)2011-01-20
RU2580299C2 (en)2016-04-10
NZ597858A (en)2014-01-31
MX2012000158A (en)2012-06-08
SG10201403702SA (en)2014-09-26
US11207375B2 (en)2021-12-28
CN107126557A (en)2017-09-05
US10105412B2 (en)2018-10-23
EP2448592A1 (en)2012-05-09
EP2448592B1 (en)2020-06-17
EP2448592A4 (en)2013-04-24
CN102548572A (en)2012-07-04
JP5931724B2 (en)2016-06-08
AU2010273708A8 (en)2012-06-14
WO2011008548A8 (en)2012-03-08
RU2011153032A (en)2013-08-10

Similar Documents

PublicationPublication DateTitle
IN2012DN00791A (en)
MY163871A (en)Vaccines and compositions against streptococcus pneumoniae
IL219876A (en)Antibody or fragment thereof against human b7-h1, compositions comprising same and use thereof in the preparation of medicaments
MX2009009931A (en)Probiotics to reduce development of allergy in infants born by caesarean section.
LT2493474T (en) METHODS AND COMPOSITIONS FOR PROLONGED MEDICINAL ADMINISTRATION
ZA201109537B (en)Novel conjugates, preparation thereof,and therapeutic use thereof
MX2009011500A (en)Anti-mdl-1 antibodies.
IL211842A (en)Antibody or human tgfbrii-binding fragment thereof, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for inhibiting angiogenesis
MX2011011505A (en)Pneumococcal vaccine and uses thereof.
IL216582A0 (en)Composition for use in decreasing the transmission of human pathogens, devices comprising the same and uses thereof
MX366368B (en)Prebiotic oral care methods using a saccharide.
IL220801A0 (en)Pad, in particular for use in the nursing care and hospital sector
MX2011007456A (en)Cna_b domain antigens in vaccines against gram positive bacteria.
AP2012006292A0 (en)Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection.
WO2013109995A3 (en)Fused antigen vaccines and compositions against streptococcus pneumoniae
MX2016000099A (en)Synthetic vaccines against streptococcus pneumoniae type 1.
MX342832B (en)Treatment or prevention of infection.
WO2009115509A3 (en)Antigenic protein fragments of streptococcus pneumoniae
ZA201104882B (en)Pharmaceutical compositions with superior product performance and patient compliance
IL206438A0 (en)The vicky' nursing pillow
IL194353A0 (en)Lysobactin amides
TN2012000217A1 (en)The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease
UA105944C2 (en)Drug formulation with theobromine and decongestant for treatment of cough
TR200909786A1 (en) Effervescent tablet and granule formulation containing cefixime.
MX2010004734A (en)Novel antiretroviral combination.
[8]ページ先頭
©2009-2025 Movatter.jp